Utilization and related harms of systemic glucocorticosteroids for atopic dermatitis: claims data analysis

  • Published on 07/29/2024
  •  Reading time: 4 min.

Kristina Hagenström, Theresa Klinger, Katharina Müller, Charlotte Willers, Matthias Augustin

Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany

Corresponding author: Kristina Hagenström, Email:k.hagenstroem@uke.de

Abstract

Background and objectives Systemic glucocorticosteroids (SGCs) are used in the short-term treatment of atopic dermatitis (AD), but are not recommended for long-term use since associated with severe side effects. This study aimed to characterize the utilization and potentially negative effects of SGC use for AD in German statutory health insurance (SHI) claims data.
Patients and methods Cross-sectional and longitudinal analysis of a large nationwide SHI...

ContentGeneMD

To continue reading this article in Full-Text...

* Access is totally free, without commitment or condition. Service exclusively reserved for healthcare professionals.

Peer-Reviewed Journals A-Z

Search | Advanced search

Get the latest news in Dermatology

Receive our newsletter to stay up to date with the latest news in Dermatology